Cite
APA Citation
Rasmussen, R. M., Kurzman, I. D., Biller, B. J., Guth, A., & Vail, D. M. (n.d.). phase I lead‐in and subsequent randomized trial assessing safety and modulation of regulatory T cell numbers following a maximally tolerated dose doxorubicin and metronomic dose cyclophosphamide combination chemotherapy protocol in tumour‐bearing dogs. Veterinary and comparative oncology, 15, 421–430. http://access.bl.uk/ark:/81055/vdc_100183000960.0x000016